DEA To Rule Shortly On Reclassifying Synthetic THC

DEA To Rule Shortly On Reclassifying Synthetic THC
Posted by FoM on December 10, 1998 at 09:45:02 PT
Thank You NORML for all you do!
 Washington, DC: Drug Enforcement Administration (DEA) officials will decide shortly whether to reclassify synthetic THC, marketed as the drug Marinol, as a Schedule III drug. The public had until December 7, 1998, to file comments, objections, and requests for a hearing on the proposed reclassification. 
Federal officials announced their intent shortly after voters this fall approved the use of Marijuana as a medicine in five states. Marinol is an oral medication approved as an anti-nauseant for patients undergoing cancer chemotherapy, and as an appetite stimulant for patients suffering from HIV or AIDS. It is presently classified as a Schedule II drug, the most restrictive category a legal drug can be placed in. "Marinol is a legal alternative to Marijuana that has demonstrated varied effectiveness among patient populations," NORML Foundation Publications Director Paul Armentano said. "Marinol often provides only limited relief to a select group of patients, particularly when compared to whole smoked marijuana therapy. Marinol should remain an option to patients, but its availability should not preclude amending federal law to allow those patients unresponsive to synthetic THC the opportunity to use inhaled Marijuana as a legal medical therapy." For more information, please contact Paul Armentano of The NORML Foundation   (202) 483-8751. Copies of the NORML report: The Need for Medical Marijuana Despite the Availability of Synthetic THC are available upon request. Hopefully this will lead to Marijuana being re-scheduled too!
Home Comment Email Register Recent Comments Help

Post Comment

Name: Optional Password: 
Comment: [Please refrain from using profanity in your message]
Link URL: 
Link Title: